What is he best known for?
The fields of study he is best known for:
Peter ten Dijke mostly deals with SMAD, Signal transduction, Cancer research, Cell biology and Transforming growth factor.
His SMAD research is multidisciplinary, relying on both R-SMAD, Transcription factor and Hedgehog signaling pathway.
His Signal transduction research is multidisciplinary, incorporating elements of Receptor, Phosphorylation and Gefitinib.
His work deals with themes such as Epithelial–mesenchymal transition, Metastasis and Immunology, which intersect with Cancer research.
His Cell biology study combines topics from a wide range of disciplines, such as Cellular differentiation, Internal medicine, Bone morphogenetic protein and Endocrinology.
The Transforming growth factor study combines topics in areas such as Cancer and Transforming growth factor, beta 3.
His most cited work include:
- TGF-beta signalling from cell membrane to nucleus through SMAD proteins (3313 citations)
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. (893 citations)
- TGF-β in progression of liver disease (404 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cell biology, Cancer research, Transforming growth factor, SMAD and Signal transduction.
His Cell biology study integrates concerns from other disciplines, such as Receptor, Endocrinology and Bone morphogenetic protein.
Peter ten Dijke has included themes like Cancer cell, Cancer, Breast cancer, Metastasis and Transforming growth factor beta in his Cancer research study.
His biological study spans a wide range of topics, including Fibrosis, Extracellular matrix, Transforming growth factor, beta 3 and Cell growth.
His work in SMAD tackles topics such as Molecular biology which are related to areas like TGF beta receptor 2.
His Signal transduction study incorporates themes from Epithelial–mesenchymal transition, Ubiquitin, Mesenchymal stem cell and Immunology.
He most often published in these fields:
- Cell biology (47.33%)
- Cancer research (45.04%)
- Transforming growth factor (41.22%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (45.04%)
- Cell biology (47.33%)
- Transforming growth factor (41.22%)
In recent papers he was focusing on the following fields of study:
Peter ten Dijke focuses on Cancer research, Cell biology, Transforming growth factor, Signal transduction and SMAD.
His Cancer research research is multidisciplinary, incorporating elements of Bladder cancer, Cancer, Metastasis, Cancer cell and Transforming growth factor beta.
The various areas that Peter ten Dijke examines in his Cell biology study include In vitro, Ubiquitin and Bone morphogenetic protein.
His studies in Transforming growth factor integrate themes in fields like Slug, Regulation of gene expression and Transcription factor.
The Signal transduction study combines topics in areas such as Cell, Tissue homeostasis and Mesoderm.
He studied SMAD and Crosstalk that intersect with Neuroscience.
Between 2018 and 2021, his most popular works were:
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis (151 citations)
- Bone morphogenetic protein receptor signal transduction in human disease. (56 citations)
- The therapeutic potential of targeting the endothelial-to-mesenchymal transition. (37 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Cancer research, Signal transduction, Metastasis, Transforming growth factor and Cancer cell.
His work deals with themes such as Carcinogenesis, Transforming growth factor beta, Downregulation and upregulation and Bone morphogenetic protein, which intersect with Cancer research.
His Signal transduction research is classified as research in Cell biology.
His Cell biology research incorporates themes from Tissue engineering and Angiogenesis.
His research investigates the connection between Transforming growth factor and topics such as Cancer that intersect with problems in Immune system, Immunogenicity, Immunology and Blockade.
His biological study spans a wide range of topics, including Glycolysis and TGF beta signaling pathway.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
